Post Profile






Becton Dickinson blood tubes not linked to inaccurate lead results: FDA

(Reuters) - Blood collection tubes made by Becton Dickinson & Co that were used in conjunction with Magellan Diagnostics' lead-testing devices were not linked to the cause of inaccurate results of lead levels, the U.S. Food and Drug Administration said on Thursday.
read more

share

Related Posts


BD Announces FDA 510(k) Clearance Of BD ProbeTecâ„¢ Qx Amplified Assays For The Detection Of Chlamydia Trachomatis And Neisseria Gonorrhoeae

Health : Medical News Today

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTecâ„¢ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD...

BD Announces FDA 510(k) Clearance Of Novel Molecular Assay To Diagnose Clostridium Difficile Infections

Health : Medical News Today

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection o...

BD Receives FDA Approval For The BD FocalPoint(TM) GS Imaging System To Enhance The Detection Of Cervical Cancer

Health : Medical News Today

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.

FDA expands use of AstraZeneca/Merck ovarian cancer drug

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have responded to pla...

FDA approves Pfizer's drug for rare blood cancer

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's treatment for a rare type of blood cancer.

Comments


Copyright © 2016 Regator, LLC